This certificate is awarded to T. Jeroen N. Hiltermann in recognition of the great contribution entitled "Novel immune checkpoint inhibitor strategies in advanced non-small cell lung cancer: towards biomarker-driven therapies?" to Translational Lung Cancer Research.
